Date published: 2025-9-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

Morantel citrate salt (CAS 69525-81-1)

0.0(0)
Write a reviewAsk a question

Alternate Names:
1,4,5,6-Tetrahydro-1-methyl-2-(2-[3-methyl-2-thienyl]ethenyl)pyrimidine
Application:
Morantel citrate salt is a potent non-binding site acetylcholine (ACh) receptor agonist and inhibits fumarate reductase
CAS Number:
69525-81-1
Molecular Weight:
412.46
Molecular Formula:
C12H16N2S•C6H8O7
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Morantel citrate salt, with the CAS number 69525-81-1, is a chemical compound classified under the tetrahydropyrimidine group. It is known for its action as an agonist to the nicotinic acetylcholine receptors located on the muscle cells of nematodes. By binding to these receptors, morantel citrate salt induces a prolonged opening of the receptor-associated ion channels, allowing an excessive influx of cations, particularly sodium ions, into the muscle cells. This results in a sustained depolarization of the muscle membrane, which disrupts normal neuromuscular transmission and leads to spastic paralysis of the affected nematodes. The paralysis prevents the nematodes from maintaining their position within the host, leading to their expulsion. In research contexts, morantel citrate salt is utilized to study the neuromuscular systems of parasitic nematodes, providing insights into the specific interactions between the chemical and the nicotinic acetylcholine receptors. These studies are crucial for understanding how modifications in the receptor or the compound could influence the efficacy and specificity of this type of intervention. Furthermore, research involving morantel citrate salt helps in exploring resistance mechanisms that nematodes develop, which is essential for managing resistance and improving control strategies against parasitic infections in various environments.


Morantel citrate salt (CAS 69525-81-1) References

  1. Pharmacokinetic disposition and faecal excretion of pyrantel embonate following oral administration in horses.  |  Gokbulut, C., et al. 2001. J Vet Pharmacol Ther. 24: 77-9. PMID: 11348490
  2. Morantel resistance in Trichostrongylus colubriformis.  |  McKenna, PB. and Seifert, DA. 1985. N Z Vet J. 33: 166-7. PMID: 16031100
  3. Effect of liquid whey feeding on fecal microbiota of mature and growing pigs.  |  Kobayashi, Y., et al. 2011. Anim Sci J. 82: 607-15. PMID: 21794022
  4. Evaluation of a multi-class, multi-residue liquid chromatography-tandem mass spectrometry method for analysis of 120 veterinary drugs in bovine kidney.  |  Schneider, MJ., et al. 2012. Drug Test Anal. 4 Suppl 1: 91-102. PMID: 22851365
  5. Plasma pharmacokinetics, faecal excretion and efficacy of pyrantel pamoate paste and granule formulations following per os administration in donkeys naturally infected with intestinal strongylidae.  |  Gokbulut, C., et al. 2014. Vet Parasitol. 205: 186-92. PMID: 25015542
  6. Utilization of computer processed high definition video imaging for measuring motility of microscopic nematode stages on a quantitative scale: 'The Worminator'.  |  Storey, B., et al. 2014. Int J Parasitol Drugs Drug Resist. 4: 233-43. PMID: 25516834
  7. Assessment of FDA-approved drugs against Strongyloides ratti in vitro and in vivo to identify potentially active drugs against strongyloidiasis.  |  Keiser, J. and Häberli, C. 2021. Parasit Vectors. 14: 615. PMID: 34949209
  8. Critical tests of morantel-trichlorfon paste formulation against internal parasites of the horse.  |  Drudge, JH., et al. 1984. Vet Parasitol. 14: 55-64. PMID: 6538366
  9. Activity of morantel citrate against strains of benzimidazole-resistant nematodes of sheep in the United Kingdom.  |  Coles, GC., et al. 1993. Vet Rec. 133: 156-7. PMID: 8236701

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Morantel citrate salt, 100 mg

sc-235892
100 mg
$200.00